Comparison of prevalence of nausea and vomiting after laparascopic cholecystectomy in case of pretreatment with Haloperidol and Ondansetro
- Conditions
- aparoscopy Cholecystectomy.Calculus of gallbladder with other cholecystitisK80.1
- Registration Number
- IRCT20141009019470N85
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Age 18--60 years old
Patients undergoing laparoscopy cholecystectomy under general anesthesia
Cholelithiasis
Chronic cholecystitis
Cholecystic polyp
ASA I-II
Underlying medical condition that is currently not under control
History of allergy to drugs or use of alcohol;
Parkinson
History of glaucoma
Bone marrow depression
Severe liver disease
Obstructive bowel disease
History of prostate disease
History of cardiac arrhythmia
History of respiratory failure or respiratory distress
Taking antidepressants
History of allergy to haloperidol or ondansetron
Pregnancy
Breast feeding patients
Digestive diseases, kidney and hematology
History of dizziness or motion
Use an anti-nausea and vomiting agent within 24 hours before the surgery
Anxiety disorders,Restlessness, loss in time and place
Confusion, tremor, chills, seizure, tinnitus
History of Bradycardia
Reduced cardiac function
Low blood pressure
Surgery takes more than an hour.
Opium addiction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post-operative Nausea and Vomiting. Timepoint: Every 15 min at the recovery room and every 1 hour at the ward. Method of measurement: Bellville Scoring.
- Secondary Outcome Measures
Name Time Method ength of stay in the recovery room and the discharge time from recovery room. Timepoint: Every 15 min at the recovery room. Method of measurement: Aldrete Score.;Patients’ Satisfaction. Timepoint: At the end of the trial. Method of measurement: Likert scoring.